Finance

Lists
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
၂,၅၉၁.၈၀ ₹
+၀.၄၈%
(+၁၂.၃၀) 1D
ဩ ၇, GMT+၅:၃၀ ၁၅:၃၀:၀၂  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for GLAXO...
Open
၂,၅၇၀.၀၀ ₹
High
၂,၆၂၄.၉၀ ₹
Low
၂,၅၅၆.၅၀ ₹
Mkt. cap
ဋေ ၄.၃၉ သ
Avg. vol.
၇.၈၅ သောင်း
Volume
၃.၅၀ သောင်း
Dividend
၂.၂၀%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၁.၁၀
52-wk high
၂,၈၈၃.၄၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၃.၀၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Open
၂,၅၇၀.၀၀ ₹
High
၂,၆၂၄.၉၀ ₹
Low
၂,၅၅၆.၅၀ ₹
Mkt. cap
ဋေ ၄.၃၉ သ
Avg. vol.
၇.၈၅ သောင်း
Volume
၃.၅၀ သောင်း
Dividend
၂.၂၀%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၁.၁၀
52-wk high
၂,၈၈၃.၄၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၃.၀၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees၃.၁ ထောင်
Founded၁၉၂၄ နို ၁၃
Headquarters-
Sector-
Websiteindia-pharma.gsk.com
Last report
၂၀၂၆ ဩ ၃
Fiscal period
Q1 2027
EPS / Est. (INR)
၁၄.၀၀ ₹ / ၁၃.၉၀ ₹
+၀.၇၂%beat
Revenue / Est. (INR)
၉၃၈.၄၄ ဋေ / ၉၁၁.၁၅ ဋေ
+၃.၀၀%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၉၇၉.၉၄ ဋေ
ဋေ ၁.၀၄ ထ
၉၉၅.၃၀ ဋေ
၉၃၈.၄၄ ဋေ
Cost of goods sold
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
၃၂၇.၉၄ ဋေ
Cost of revenue
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
၃၂၇.၉၄ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၃၈.၀၅ ဋေ
၁၅၁.၈၈ ဋေ
၂၉၄.၆၈ ဋေ
၁၅၉.၀၄ ဋေ
Operating expense
၃၀၆.၁၁ ဋေ
၃၂၆.၄၂ ဋေ
၂၈၄.၁၇ ဋေ
၃၃၀.၈၄ ဋေ
Total operating expenses
၆၆၁.၆၄ ဋေ
၆၉၀.၂၄ ဋေ
၆၅၂.၇၃ ဋေ
၆၅၈.၇၈ ဋေ
Operating income
၃၁၈.၃၀ ဋေ
၃၅၁.၀၂ ဋေ
၃၄၂.၅၇ ဋေ
၂၇၉.၆၆ ဋေ
Other non operating income
၃၃.၅၇ ကုဋေ
၃၂.၁၂ ကုဋေ
-၁၀၉.၄၁ ဋေ
၄၃.၇၆ ကုဋေ
EBT including unusual items
၃၅၄.၀၀ ဋေ
၃၉၉.၉၃ ဋေ
၃၇၃.၁၀ ဋေ
၃၂၂.၄၅ ဋေ
EBT excluding unusual items
၃၅၁.၃၆ ဋေ
၃၈၁.၉၅ ဋေ
၂၉၃.၅၁ ဋေ
၃၂၂.၄၅ ဋေ
Income tax expense
၉၆.၅၁ ကုဋေ
၁၀၄.၃၁ ဋေ
၉၅.၂၄ ကုဋေ
၈၅.၂၇ ကုဋေ
Effective tax rate
၂၇.၂၆%
၂၆.၀၈%
၂၅.၅၃%
၂၆.၄၄%
Other operating expenses
၁၅၀.၆၃ ဋေ
၁၅၄.၂၂ ဋေ
-၂၃.၆၈ ကုဋေ
၁၅၅.၉၆ ဋေ
Net income
၂၅၇.၄၉ ဋေ
၂၉၅.၆၂ ဋေ
၂၇၇.၈၆ ဋေ
၂၃၇.၁၈ ဋေ
Net profit margin
၂၆.၂၈%
၂၈.၃၉%
၂၇.၉၂%
၂၅.၂၇%
Earnings per share
-
-
-
၁၄.၀၀
Interest and investment income
-
-
၆၅.၇၃ ကုဋေ
-
Interest expense
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
-၆.၁၂ သန်း
-၉.၇၀ သန်း
Net interest expenses
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
၆၅.၁၂ ကုဋေ
-၉.၇၀ သန်း
Depreciation and amortization charges
၁၇.၄၃ ကုဋေ
၂၀.၃၂ ကုဋေ
၁၃.၁၇ ကုဋေ
၁၅.၈၄ ကုဋေ
EBITDA
၃၃၄.၇၈ ဋေ
၃၆၀.၆၁ ဋေ
၃၅၂.၁၉ ဋေ
၂၈၉.၂၈ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ